The case of Paul Conyngham, an AI consultant in Sydney, has made headlines worldwide: using artificial intelligence and the support of local scientists, he managed to design an experimental treatment for his dog Rosie, diagnosed with terminal cancer.
Today, Rosie is in partial remission, with a notable reduction in her largest tumor and a recovery of mobility.
The role of artificial intelligence
Conyngham turned to chatbots like ChatGPT, Gemini, and Grok to research emerging cancer therapies.
- He paid 3,000 dollars to sequence Rosie’s genome.
- Analyzed the DNA data with online tools.
- Used AlphaFold, the AI model that won the 2024 Nobel Prize in Chemistry, to understand specific mutations.
AI did not cure the cancer, but it allowed for faster information gathering and connecting with the right scientists.
The personalized vaccine
The treatment included a personalized mRNA vaccine combined with immunotherapy. According to Professor Martin Smith from the University of New South Wales (UNSW), the combination of three disruptive technologies—genomic sequencing, AI, and RNA therapies—opens new possibilities and challenges.
The scientific team, led by Pall Thordarson, designed the mRNA sequence from the data generated with AI. Although not all tumors responded equally, the largest one shrank dramatically.
Challenges and limitations
Rosie still faces surgeries, and it is unclear how long she can remain stable. Experts warn that this case does not constitute a clinical trial and that the scientific details of the treatment have not been published. However, the example shows how AI can shorten the time between diagnosis and the design of experimental therapies.
International reactions
The story caught the attention of Sam Altman, CEO of OpenAI, who called it “incredible.” It also sparked debate in the scientific community:
- Nick Semenkovich (Medical College of Wisconsin) highlighted the potential of AI to accelerate research, though he urged caution due to the lack of published data.
- Patrick Tang Ming-kuen (Chinese University of Hong Kong) noted that AI can transform complex searches into data-driven processes, although the risk of errors is real.
Social impact
Since the case became public, the UNSW team has received multiple requests from people seeking similar solutions for pets and family members. However, researchers caution that it is not always possible to replicate these types of treatments, as they require very specific conditions and a strong scientific network.
Rosie’s story reflects the power of human determination combined with artificial intelligence. Although it is not a definitive cure, the case opens a debate on how AI can become an ally to accelerate medical research and explore new frontiers in the fight against cancer, both in animals and humans.
